Back
C4 Therapeutics 10K Form
Sell
20
CCCC
C4 Therapeutics
Last Price:
5.51
Seasonality Move:
60.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CCCC News And Ratings
See the #1 stock for the next 7 days that we like better than CCCC
CCCC Financial Statistics
Sales & Book Value
| Annual Sales: | $20.76M |
|---|---|
| Cash Flow: | $-24.12M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.44 |
| Price / Book: | 1.71 |
Profitability
| EPS (TTM): | -1.70000 |
|---|---|
| Net Income (TTM): | $-105.5M |
| Gross Margin: | -- |
| Return on Equity: | -43.59% |
| Return on Assets: | -28.28% |
C4 Therapeutics Earnings Forecast
Key C4 Therapeutics Financial Ratios
- The Research & Development expenses have been 567.09% of Revenue.
- The Interest Expense is -1.04% of Operating Income.
- The Net Earning history of CCCC is -638.34% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
C4 Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CCCC |
| CUSIP: | 12529R |
| Website: | c4therapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.31 |
| Quick Ratio: | 6.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CCCC Technical Analysis vs Fundamental Analysis
Sell
20
C4 Therapeutics (CCCC)
is a Sell
Is C4 Therapeutics a Buy or a Sell?
-
C4 Therapeutics stock is rated a Sell
The current C4 Therapeutics [CCCC] share price is $5.89. The Score for CCCC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.